Compounds > doripenem
Page last updated: 2024-08-25

doripenem and fosfomycin

doripenem has been researched along with fosfomycin in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's6 (85.71)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bernabeu, S; Nordmann, P; Poirel, L; Revathi, G1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Giamarellou, H; Poulakou, G1
Apisarnthanarak, A; Mundy, LM2
Burgmann, H; Lingscheid, T; Mitteregger, D; Poeppl, W; Tobudic, S1
Abbasi, SA; Day, KM; Paterson, DL; Perry, JD; Raza, MW; Sartor, AL; Sidjabat, HE1

Reviews

2 review(s) available for doripenem and fosfomycin

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Multidrug-resistant Gram-negative infections: what are the treatment options?
    Drugs, 2009, Oct-01, Volume: 69, Issue:14

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Minocycline; Polymyxins; Tigecycline

2009

Other Studies

5 other study(ies) available for doripenem and fosfomycin

ArticleYear
Detection of NDM-1-producing Klebsiella pneumoniae in Kenya.
    Antimicrobial agents and chemotherapy, 2011, Volume: 55, Issue:2

    Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Electrophoresis, Gel, Pulsed-Field; Female; Humans; Kenya; Klebsiella Infections; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Polymerase Chain Reaction

2011
Use of high-dose 4-hour infusion of doripenem, in combination with fosfomycin, for treatment of carbapenem-resistant Pseudomonas aeruginosa pneumonia.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2010, Dec-01, Volume: 51, Issue:11

    Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Doripenem; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Middle Aged; Pneumonia, Bacterial; Pseudomonas aeruginosa

2010
Carbapenem-resistant Pseudomonas aeruginosa pneumonia with intermediate minimum inhibitory concentrations to doripenem: combination therapy with high-dose, 4-h infusion of doripenem plus fosfomycin versus intravenous colistin plus fosfomycin.
    International journal of antimicrobial agents, 2012, Volume: 39, Issue:3

    Topics: Carbapenems; Colistin; Cross Infection; Doripenem; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fosfomycin; Humans; Infusions, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Pneumonia, Ventilator-Associated; Pseudomonas aeruginosa; Retrospective Studies; Time Factors

2012
In vitro activity of doripenem plus fosfomycin against drug-resistant clinical blood isolates.
    Pharmacology, 2013, Volume: 91, Issue:3-4

    Topics: Anti-Bacterial Agents; Carbapenems; Doripenem; Drug Resistance, Multiple, Bacterial; Fosfomycin; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests

2013
Molecular epidemiology of NDM-1-producing Enterobacteriaceae and Acinetobacter baumannii isolates from Pakistan.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:9

    Topics: Acinetobacter baumannii; Amdinocillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cross Infection; DNA, Bacterial; Doripenem; Enterobacteriaceae; Fosfomycin; Humans; Meropenem; Methyltransferases; Microbial Sensitivity Tests; Molecular Epidemiology; Multilocus Sequence Typing; Pakistan; Thienamycins

2014